Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung
Spigel, David R, Edelman, Martin J, O'Byrne, Kenneth, Paz-Ares, Luis, Mocci, Simonetta, Phan, See, Shames, David S, Smith, Dustin, Yu, Wei, Paton, Virginia E, Mok, Tony
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial
Friedlander, Michael, Prof, Meniawy, Tarek, PhD, Markman, Ben, MBBS, Mileshkin, Linda, MD, Harnett, Paul, Prof, Millward, Michael, MBBS, Lundy, Joanne, MBBS, Freimund, Alison, MBBS, Norris, Christie, RN, Mu, Song, PhD, Wu, John, PhD, Paton, Virginia, PharmD, Gao, Bo, PhD
Published in The lancet oncology (01.09.2019)
Published in The lancet oncology (01.09.2019)
Get full text
Journal Article
Independent Adjudication of Symptomatic Heart Failure With the Use of Doxorubicin and Cyclophosphamide Followed by Trastuzumab Adjuvant Therapy: A Combined Review of Cardiac Data From the National Surgical Adjuvant Breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 Clinical Trials
RUSSELL, Stuart D, BLACKWELL, Kimberly L, LAWRENCE, Julia, PIPPEN, John E, ROE, Matthew T, WOOD, Freda, PATON, Virginia, HOLMGREN, Eric, MAHAFFEY, Kenneth W
Published in Journal of clinical oncology (20.07.2010)
Published in Journal of clinical oncology (20.07.2010)
Get full text
Journal Article
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors
Desai, Jayesh, Deva, Sanjeev, Lee, Jong Seok, Lin, Chia-Chi, Yen, Chia-Jui, Chao, Yee, Keam, Bhumsuk, Jameson, Michael, Hou, Ming-Mo, Kang, Yoon-Koo, Markman, Ben, Lu, Chang-Hsien, Rau, Kun-Ming, Lee, Kyung-Hun, Horvath, Lisa, Friedlander, Michael, Hill, Andrew, Sandhu, Shahneen, Barlow, Paula, Wu, Chi-Yuan, Zhang, Yun, Liang, Liang, Wu, John, Paton, Virginia, Millward, Michael
Published in Journal for immunotherapy of cancer (14.06.2020)
Published in Journal for immunotherapy of cancer (14.06.2020)
Get full text
Journal Article
Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
MAKHIJA, Sharmila, AMLER, Lukas C, STRAUSS, Andreas, KELSEY, Stephen, SLIWKOWSKI, Mark X, MATULONIS, Ursula, GLENN, Dana, UELAND, Frederick R, GOLD, Michael A, DIZON, Don S, PATON, Virginia, LIN, Chin-Yu, JANUARIO, Thomas, NG, Kimmie
Published in Journal of clinical oncology (01.03.2010)
Published in Journal of clinical oncology (01.03.2010)
Get full text
Journal Article
Safety of Onartuzumab in Patients with Solid Tumors: Experience to Date from the Onartuzumab Clinical Trial Program
Morley, Roland, Cardenas, Alison, Hawkins, Peter, Suzuki, Yasuyo, Paton, Virginia, Phan, See-Chun, Merchant, Mark, Hsu, Jessie, Yu, Wei, Xia, Qi, Koralek, Daniel, Luhn, Patricia, Aldairy, Wassim
Published in PloS one (07.10.2015)
Published in PloS one (07.10.2015)
Get full text
Journal Article
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
COBLEIGH, M. A, VOGEL, C. L, SLAMON, D. J, TRIPATHY, D, ROBERT, N. J, SCHOLL, S, FEHRENBACHER, L, WOLTER, J. M, PATON, V, SHAK, S, LIEBERMAN, G
Published in Journal of clinical oncology (01.09.1999)
Published in Journal of clinical oncology (01.09.1999)
Get full text
Journal Article
736 A phase 1/2 open-label, dose-escalation study of ST-067, a decoy-resistant IL-18 cytokine, given as a monotherapy and with pembrolizumab in advanced solid tumor malignancies
Moser, Justin C, Sullivan, Ryan, Taylor, Matthew H, Puzanov, Igor, Falchook, Gerald S, Sznol, Mario, Paton, Virginia E, Chonzi, David, Garofalo, Brage, Sonnemann, Mark, Uppal, Hirdesh, Barton, Jeremy, McQueen, Beatrice Y, Ring, Aaron M, Kluger, Harriet
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
Onartuzumab plus erlotinib versus erlotinib in previously treated stage IIIb or IV NSCLC: Results from the pivotal phase III randomized, multicenter, placebo-controlled METLung (OAM4971g) global trial
Spigel, David R., Edelman, Martin J., O'Byrne, Kenneth, Paz-Ares, Luis, Shames, David S., Yu, Wei, Paton, Virginia E., Mok, Tony
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Effect of Cardiac Dysfunction on Treatment Outcomes in Women Receiving Trastuzumab for HER2-Overexpressing Metastatic Breast Cancer
Tripathy, Debu, Seidman, Andrew, Keefe, Deborah, Hudis, Clifford, Paton, Virginia, Lieberman, Grazyna
Published in Clinical breast cancer (01.10.2004)
Published in Clinical breast cancer (01.10.2004)
Get full text
Journal Article
Abstract OT1-12-02: Trial in progress: Phase 2, open-label study to evaluate the safety and efficacy of praluzatamab ravtansine in metastatic HER2 non-amplified breast cancer as monotherapy and combination with pacmilimab
Miller, Kathy, Emens, Leisha A., Tolaney, Sara M., Hurvitz, Sara A., Hamilton, Erika, Paton, Virginia, Hannah, Alison, Boni, Valentina
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Abstract OT-03-08: A Phase 2, open-label study to evaluate the safety and efficacy of the probody therapeutic (Pb-Tx) CX-2009 in metastatic HR-Positive/HER2-negative breast cancer (mHR+/HER2− BC) and of CX-2009 as monotherapy and in combination therapy with CX-072 in metastatic triple-negative breast cancer (TNBC)
Miller, Kathy D., Emens, Leisha A., Tolaney, Sara, Hurvitz, Sara A., Hamilton, Erika, Paton, Virginia, Hannah, Alison, Boni, Valentina
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial
Boni, Valentina, Fidler, Mary J, Arkenau, Hendrik-Tobias, Spira, Alexander, Meric-Bernstam, Funda, Uboha, Nataliya, Sanborn, Rachel E, Sweis, Randy F, LoRusso, Patricia, Nagasaka, Misako, Garcia-Corbacho, Javier, Jalal, Shadia, Harding, James J, Kim, Stella K, Miedema, Iris H C, Vugts, Danielle J, Huisman, Marc C, Zwezerijnen, Gerben J C, van Dongen, Guus A M S, Menke van der Houven van Oordt, C Willemien, Wang, Song, Dang, Tam, Zein, Ivan A, Vasiljeva, Olga, Lyman, Susan K, Paton, Virginia, Hannah, Alison, Liu, Joyce F
Published in Clinical cancer research (13.05.2022)
Published in Clinical cancer research (13.05.2022)
Get full text
Journal Article
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
Cobleigh, Melody A, Vogel, Charles L, Tripathy, Debu, Robert, Nicholas J, Scholl, Susy, Fehrenbacher, Louis, Wolter, Janet M, Paton, Virginia, Shak, Steven, Lieberman, Gracie, Slamon, Dennis J
Published in Journal of clinical oncology (10.03.2023)
Published in Journal of clinical oncology (10.03.2023)
Get full text
Journal Article
Abstract PS11-07: Intratumoral activation and phase 1/2 clinical activity of CX-2009, a probody drug conjugate (PDC) targeting CD166
Liu, Joyce F., Zein, Ivan A., Dang, Tam, Lyman, Susan K., Spira, Alexander, Uboha, Nataliya, LoRusso, Patricia, Fidler, Mary J., Meric-Bernstam, Funda, Arkenau, Tobias, Nagasaka, Misako, Desnoyers, Luc R., Kavanaugh, William M., Paton, Virginia, Hannah, Alison, Boni, Valentina
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article